Will TEMPO Accelerate Your Market ACCESS and Reimbursement? FDA’s New Pilot Program Offers Enforcement Discretion for Certain Digital Health Technologies

Will TEMPO Accelerate Your Market ACCESS and Reimbursement? FDA’s New Pilot Program Offers Enforcement Discretion for Certain Digital Health Technologies

In a move aimed at tying reimbursement to patient outcomes, the Centers for Medicare & Medicaid Services (CMS) Innovation Center announced the “Advancing Chronic Care with Effective Scalable Solutions” (ACCESS) model, a…

Continue Reading